Literature DB >> 18376071

Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes.

Pidaran Murugan1, Leelavinothan Pari, Chippada Appa Rao.   

Abstract

Curcumin is the most active component of turmeric. It is believed that curcumin is a potent antioxidant and anti-inflammatory agent. Tetrahydrocurcumin (THC) is one of the major metabolites of curcumin, and exhibits many of the same physiological and pharmacological activities as curcumin and, in some systems, may exert greater antioxidant activity than curcumin. Using circulating erythrocytes as the cellular mode, the insulin-binding effect of THC and curcumin was investigated. Streptozotocin (STZ)-nicotinamide-induced male Wistar rats were used as the experimental models. THC (80 mg/kg body weight) was administered orally for 45 days. The effect of THC on blood glucose, plasma insulin and insulin binding to its receptor on the cell membrane of erythrocytes were studied. Mean specific binding of insulin was significantly lowered in diabetic rats with a decrease in plasma insulin. This was due to a significant decrease in mean insulin receptors. Erythrocytes from diabetic rats showed a decreased ability for insulin-receptor binding when compared with THC-treated diabetic rats. Scatchard analysis demonstrated that the decrease in insulin binding was accounted for by a decrease in insulin receptor sites per cell, with erythrocytes of diabetic rats having less insulin receptor sites per cell than THC-treated rats. High affinity (K d1), low affinity (K d2) and kinetic analyses revealed an increase in the average receptor affinity of erythrocytes from THC-treated rats compared with those of diabetic rats. These results suggest that acute alteration of the insulin receptor on the membranes of erythrocytes occurred in diabetic rats. Treatment with THC significantly improved specific insulin binding to the receptors, with receptor numbers and affinity binding reaching near-normal levels. Our study suggests the mechanism by which THC increases the number of total cellular insulin binding sites resulting in a significant increase in plasma insulin. The effect of THC is more prominent than that of curcumin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376071     DOI: 10.1007/s12038-008-0022-y

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  47 in total

1.  The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits.

Authors:  Michitaka Naito; Xiaohong Wu; Hideki Nomura; Michiteru Kodama; Yuriko Kato; Yoji Kato; Toshihiko Osawa
Journal:  J Atheroscler Thromb       Date:  2002       Impact factor: 4.928

2.  Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats.

Authors:  Pidaran Murugan; Leelavinothan Pari
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-08       Impact factor: 4.080

Review 3.  Free-radical mechanisms in tissue injury.

Authors:  T F Slater
Journal:  Biochem J       Date:  1984-08-15       Impact factor: 3.857

4.  Effect of Scoparia dulcis extract on insulin receptors in streptozotocin induced diabetic rats: studies on insulin binding to erythrocytes.

Authors:  Leelavinothan Pari; Muniappan Latha; Chippada Appa Rao
Journal:  J Basic Clin Physiol Pharmacol       Date:  2004

5.  Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide.

Authors:  P Masiello; C Broca; R Gross; M Roye; M Manteghetti; D Hillaire-Buys; M Novelli; G Ribes
Journal:  Diabetes       Date:  1998-02       Impact factor: 9.461

6.  Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats.

Authors:  Palla Suryanarayana; Megha Saraswat; Tiruvalluru Mrudula; T Prasanna Krishna; Kamala Krishnaswamy; G Bhanuprakash Reddy
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-06       Impact factor: 4.799

7.  Diet- and diabetes-induced change in insulin binding to the nuclear membrane in spontaneously diabetic rats is associated with change in the fatty acid composition of phosphatidylinositol.

Authors:  S K. Cheema; M T. Clandinin
Journal:  J Nutr Biochem       Date:  2001-04       Impact factor: 6.048

8.  Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

Authors:  M Garcia-Alloza; L A Borrelli; A Rozkalne; B T Hyman; B J Bacskai
Journal:  J Neurochem       Date:  2007-04-30       Impact factor: 5.372

9.  Structure of the human erythrocyte insulin receptor.

Authors:  G M Ward; L C Harrison
Journal:  Diabetes       Date:  1986-01       Impact factor: 9.461

10.  Increased insulin binding to erythrocytes in chronic liver disease.

Authors:  Y Okada
Journal:  Acta Med Okayama       Date:  1981-06       Impact factor: 0.892

View more
  9 in total

1.  Investigation of the Effects of Difluorinated Curcumin on Glycemic Indices in Streptozotocin-Induced Diabetic Rats.

Authors:  Shabnam Radbakhsh; Amir Abbas Momtazi-Borojeni; Ali Mahmoudi; Mohammad Reza Sarborji; Mahdi Hatamipour; Seyed Adel Moallem; Stephen L Atkin; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Antidiabetic Action of Mcy Protein: Studies on Gene Expression and Competitive Binding to Insulin Receptors.

Authors:  Saritha Marella; Peddanna Kotha; S Abdul Nabi; B P Girish; Kameswara Rao Badri; Apparao Chippada
Journal:  Appl Biochem Biotechnol       Date:  2022-04-08       Impact factor: 3.094

3.  Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress.

Authors:  Jianguo Lin; Shizhong Zheng; Anping Chen
Journal:  Lab Invest       Date:  2009-10-19       Impact factor: 5.662

4.  Development, characterization and permeability assessment based on caco-2 monolayers of self-microemulsifying floating tablets of tetrahydrocurcumin.

Authors:  Namfa Sermkaew; Kamonthip Wiwattanawongsa; Wichan Ketjinda; Ruedeekorn Wiwattanapatapee
Journal:  AAPS PharmSciTech       Date:  2013-01-15       Impact factor: 3.246

5.  Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s).

Authors:  Vânia Ortega Gutierres; Michel Leandro Campos; Carlos Alberto Arcaro; Renata Pires Assis; Helen Mariana Baldan-Cimatti; Rosângela Gonçalves Peccinini; Silvia Paula-Gomes; Isis Carmo Kettelhut; Amanda Martins Baviera; Iguatemy Lourenço Brunetti
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-03       Impact factor: 2.629

6.  Acute and subchronic oral toxicity studies of hydrogenated curcuminoid formulation 'CuroWhite' in rats.

Authors:  Sreeraj Gopi; Joby Jacob; Kotrappa Y Mathur
Journal:  Toxicol Rep       Date:  2016-10-25

Review 7.  Curcumin and diabetes: a systematic review.

Authors:  Dong-Wei Zhang; Min Fu; Si-Hua Gao; Jun-Li Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-24       Impact factor: 2.629

Review 8.  Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus.

Authors:  Aminu Mohammed; Md Shahidul Islam
Journal:  Front Pharmacol       Date:  2018-08-22       Impact factor: 5.810

9.  Neuroprotective Effects of Tetrahydrocurcumin against Glutamate-Induced Oxidative Stress in Hippocampal HT22 Cells.

Authors:  Chang-Hyun Park; Ji Hoon Song; Su-Nam Kim; Ji Hwan Lee; Hae-Jeung Lee; Ki Sung Kang; Hyung-Ho Lim
Journal:  Molecules       Date:  2019-12-30       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.